Top Story

National HPV vaccination shows promise in Australia

September 2, 2014

Among young people in Australia, a significant decline has been reported in hospital admissions related to a diagnosis of genital warts since the introduction of a national HPV vaccination program, according to recent findings.

Notably, there has been a 90% decrease in genital warts among women aged 12 and 17 years, the researchers wrote.

figure In the Journals

Routine vaccination rates increased, remained stable in 2013

August 29, 2014
Vaccination coverage for all routinely recommended childhood vaccines increased or remained stable in 2013, according to study findings in MMWR.Laurie D. Elam-Evans
figure In the Journals

Pertussis vaccination rates unchanged after epidemic

August 22, 2014
Recent data show no increase in pertussis vaccination rates occurred following the 2011-2012 pertussis outbreak in Washington State.Elizabeth R. Wolf, MD, MPH, of…
figure In the Journals

Changing focus of HPV vaccine discussion could increase immunization rates

August 21, 2014
Missed opportunities for HPV vaccination are related to parents’ and physicians’ assumptions about the timing of vaccination relative to onset of sexual…

In the Pink! A Closer Look at Pediatric Conjunctivitis

This activity is supported by an educational grant from Alcon.

Bacterial conjunctivitis is the most common conjunctivitis in infants and preschool-aged children. Pediatricians must…
More »

HPV Disease Update 2013: What Every Pediatric Health Care Professional Needs to Know

This activity is supported by an educational grant from Merck & Co., Inc.

This CME-certified activity is based on the slides and lectures of faculty presenting at the Infectious Diseases in
More »

Filter By:

In the Journals Perspective

ART programs in low-resource settings in need of TB diagnostic tools

April 9, 2014
Antiretroviral therapy programs in low- and middle-income countries are still in need of tuberculosis diagnostic tools to help identify tuberculosis…
FDA News

FDA expands indication for Tdap vaccine to include 10-year-olds

April 1, 2014
Sanofi Pasteur announced that the FDA has expanded the approved age indication for its tetanus-diphtheria-acellular pertussis vaccine for patients…
In the Journals

Human coronaviruses common in young children, may present with coinfection

April 1, 2014
In children younger than 5 years, infections with human coronaviruses OC43 and NL63 are common, and they may be characterized by lower respiratory…

WHO: Polio eliminated from Southeast Asia

March 27, 2014
The Southeast Asia region of WHO has been declared “polio-free,” according to a news release. The region is the fourth of six regions to…
Institution Notes

University of Alabama at Birmingham receives $35 million for infectious disease research

March 26, 2014
The University of Alabama at Birmingham has been awarded $35 million from the National Institute of Allergy and Infectious Diseases to establish a…
In the Journals

Number of child TB cases may be double the WHO estimate

March 25, 2014
Recent data suggest that nearly 1 million children acquire tuberculosis annually, and nearly 32,000 of these are multidrug-resistant cases.This is…

Pregnancy may increase risk for H. influenzae infection

March 25, 2014
In England and Wales, the risk for invasive Haemophilus influenzae appears to be increased in pregnant women, and this risk leads to poor pregnancy…
In the Journals

At-risk girls least likely to be offered HPV vaccine

March 21, 2014
Adolescent girls in the United Kingdom who are at the greatest risk for acquiring HPV are the least likely to be offered the vaccine and to complete…
In the Journals

Infliximab failed to reduce treatment resistance of Kawasaki disease

March 13, 2014
The addition of infliximab to standard therapy for Kawasaki disease does not appear to decrease treatment resistance, but it may reduce fever…
Industry News

Chimerix releases brincidofovir for trial adenovirus treatment

March 12, 2014
Chimerix Inc. today announced that, in agreement with the FDA, it will provide a pilot trial of the open-label, broad spectrum antiviral…
More Headlines »